Cell or drug encapsulation device having a wet seal

Inactive Publication Date: 2007-02-01
WL GORE & ASSOC INC
View PDF26 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0019] In one aspect, the present invention provides a method of loading a containment device comprising creating a closed cell-tight system, the system including the containment device and a source of metabolically active cells. Loading a containment region of the device with the metabolically active cells vi

Problems solved by technology

Given the nature of the membranes, it is known that sealing a wet membrane can be difficult or impossible.
This is because known glues and solvents that are appropriate for membranes in a dry state are frequently not compatible with a wet membrane, or are toxic to cell suspensions loaded into the membrane structure.
With implantable devices, the mechanical seal dimensions are small and can be difficult to reliably manipulate.
In addition, because the loading and sealing operations can be distinct, there is an opportunity for contamination of the device exterior with cells from the cell suspension after the loading operation.
The solvents described may be toxic to the cell suspension, however.
This action presents a strong possibility of contaminating the loading

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cell or drug encapsulation device having a wet seal
  • Cell or drug encapsulation device having a wet seal
  • Cell or drug encapsulation device having a wet seal

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0045] The invention provides a containment device, methods of making the device and methods of loading and sealing the device. The containment device is particularly suited for use as a medical device, such as a cell encapsulation device, a drug delivery device, or a gene therapy device. The containment device may be inserted into a previously implanted containment apparatus residing within a recipient, such as an animal or human, or it may be implanted directly in a recipient. The device includes a permeable membrane, which partially defines an enclosed space of the device, and a closure region of the device. Materials (e.g., cells, or drugs) are loaded into the device from a loading device through the closure region into a containment region, after which the closure region is treated to form a closure. The closure is typically created by heating a thermoplastic polymer associated with the permeable membrane in the presence of a liquid that wets at least a portion of the membrane ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Pressureaaaaaaaaaa
Permeabilityaaaaaaaaaa
Heataaaaaaaaaa
Login to view more

Abstract

A biologically implantable containment device having a wet seal, the device being adaptable for drug formulations or cell suspensions. A porous membrane, in a tubular configuration, is formed and can be configured as part of a closed cell-tight system for loading. During loading, the containment device membrane is wet, while the loading system remains cell-tight. The containment device is wet-sealed through a combination of heat and pressure, while the system remains cell-tight. Sealing the containment device substantially or completely eliminates metabolic functioning of any organisms in the vicinity of the closure. The wet-seal is formed by melting a thermoplastic material that is in contact with the membrane. The containment device is separated from the cell-tight loading system, which remains closed after separation.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application is a continuation of co-pending application Ser. No. 10 / 462,915, which is a division of application Ser. No. 09 / 515,264 filed Feb. 29, 2000, now U.S. Pat. No. 6,617,151.BACKGROUND OF THE INVENTION [0002] 1. Field of the Invention [0003] The invention relates to the field of implantable devices and more particularly to devices that are wet-sealed. [0004] 2. Background Information [0005] Within the field of implantable devices, it is known to provide permeable membrane structures for implantation, the structures configured to hold drug formulations or cellular suspensions. A number of techniques have been proposed to form those structures and seal the structures. In the majority of those known techniques, the device is manufactured without the cellular suspension or drug formulation. Subsequent loading of the cellular suspension or drug formulation may occur outside a host or after the device is implanted into the host. W...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12M3/00A61K9/48A61D7/00A61F2/02A61K9/00A61K45/00A61K47/32A61K48/00A61L27/00A61L29/00A61M37/00
CPCA61K9/0024A61F2/022
Inventor NEWMAN, STEVEN C.KRAM, BRIAN H.HUBBARD, TERRY A.
Owner WL GORE & ASSOC INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products